| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/23/2012 | US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors |
| 02/23/2012 | US20120046301 Substituted Cyclic Carboxamide and Urea Derivatives as Ligands of the Vanilloid Receptor |
| 02/23/2012 | US20120046296 Palatable ductile chewable veterinary composition |
| 02/23/2012 | US20120046294 Compounds for the Treatment of Hepatitis C |
| 02/23/2012 | US20120046291 Extended Triterpene Derivatives |
| 02/23/2012 | US20120046290 Inhibition of p38 kinase activity using substituted heterocyclic ureas |
| 02/23/2012 | US20120046286 Novel Compounds |
| 02/23/2012 | US20120046282 Methods and compounds for antimicrobial intervention |
| 02/23/2012 | US20120046281 Rifalazil compositions and therapeutic regimens |
| 02/23/2012 | US20120046276 Tuberculosis treatment using pleuromutilin derivatives |
| 02/23/2012 | US20120046270 Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases |
| 02/23/2012 | US20120046259 Composition comprising an antibiotic and a corticosteroid |
| 02/23/2012 | US20120046255 Non-steroidal compounds |
| 02/23/2012 | US20120046246 Methods for treating osteoclast-related disease, compounds and compositions thereof |
| 02/23/2012 | US20120046243 Aminopyridine- and Aminopyrimidinecarboxamides as CXCR2 Modulators |
| 02/23/2012 | US20120046238 Coumarin compounds and their use for treating viral infection |
| 02/23/2012 | US20120046229 Modified relaxin polypeptides and their uses |
| 02/23/2012 | US20120046220 Phospholipid depot |
| 02/23/2012 | US20120045525 Mosquito repellent solution, preparation method and use thereof |
| 02/23/2012 | US20120045522 Synergistic fungicidal and algicidal compositions including 7-hydroxy-indanone benzoylhydrazones and copper |
| 02/23/2012 | US20120045521 Synergistic fungicidal and algicidal compositions including 2-hydroxyphenylaldehyde and 2-hydroxyphenylketone heterocycloylhydrazones and copper |
| 02/23/2012 | US20120045487 Multiphasic microfibers for spatially guided cell growth |
| 02/23/2012 | US20120045484 Calcium phosphate/sulfate-based bone implant composition |
| 02/23/2012 | US20120045479 Dry Powder Formulations, Vaccines and Methods |
| 02/23/2012 | US20120045474 Substrate peptide sequences for plague plasminogen activator and uses thereof |
| 02/23/2012 | US20120045473 Biomolecule Surface Display and Uses Thereof |
| 02/23/2012 | US20120045472 Biochemically Stabilized HIV-1 ENV Trimer Vaccine |
| 02/23/2012 | US20120045471 Recombinant parainfluenza virus vaccine comprising heterologous antigens derived from respiratory syncytial virus |
| 02/23/2012 | US20120045469 Vaccine |
| 02/23/2012 | US20120045468 Immunogenic Compositions and Uses Thereof |
| 02/23/2012 | US20120045467 Influenza virus vaccine composition and methods of use |
| 02/23/2012 | US20120045457 Nontypable haemophilus influenzae antigens |
| 02/23/2012 | US20120045456 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 02/23/2012 | US20120045447 T cell costimulating polypeptides and uses thereof |
| 02/23/2012 | US20120045445 Method of treating viral diseases |
| 02/23/2012 | US20120045441 Methods of treating lung disease and other inflammatory diseases |
| 02/23/2012 | US20120045438 Engineered anti-il-13 antibodies, compositions, methods and uses |
| 02/23/2012 | US20120045430 Dendrimer-like modular delivery vector |
| 02/23/2012 | US20120045415 Treatment of hepatitis c virus with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interferon-alpha 2a/2b and ribavirin |
| 02/23/2012 | US20120045414 Adjuvant combinations comprising a microbial tlr agonist, a cd40 or 4-1bb agonist, and optionally an antigen and the use thereof for inducing a synergistic enhancement in cellular immunity |
| 02/23/2012 | US20120045413 Human papilloma virus peptide-specific T-cell response for treatment of warts |
| 02/23/2012 | US20120045401 Oral composition |
| 02/23/2012 | US20120045394 Human and mouse targeting peptides identified by phage display |
| 02/23/2012 | CA2845241A1 Anti-viral carbamimidothioic acid esters |
| 02/23/2012 | CA2808679A1 Novel phytochemicals from extracts of maple syrups and maple trees and uses thereof |
| 02/23/2012 | CA2808492A1 Antifungal agents and uses thereof |
| 02/23/2012 | CA2808489A1 Anti-microbial compositions |
| 02/23/2012 | CA2808291A1 Compounds and methods for the treatment or prevention of flaviviridae viral infections |
| 02/23/2012 | CA2808165A1 Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (dcir) activity and signaling events |
| 02/23/2012 | CA2807307A1 Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina) |
| 02/22/2012 | EP2420572A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
| 02/22/2012 | EP2420500A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action |
| 02/22/2012 | EP2420496A2 Antiepileptic, hypocholesterolemic and neuroprotective compound |
| 02/22/2012 | EP2420248A1 Mutated HIV NEF for modulating immunity |
| 02/22/2012 | EP2420247A1 Adenovirus formulations |
| 02/22/2012 | EP2419433A1 Hepatitis c virus inhibitors |
| 02/22/2012 | EP2419426A1 ( pyrazol-3-yl) -1, 3, 4-thiadiazol-2-amine and ( pyrazol-3-yl) -1, 3, 4-thiazol-2-amine compounds |
| 02/22/2012 | EP2419131A1 Macrocyclic lactone combination compositions, vaccines and methods for producing same |
| 02/22/2012 | EP2419101A2 Method of treating disorders associated with protein kinase ck2 activity |
| 02/22/2012 | EP2419084A2 A medicinal cream made using clotrimazole and chitosan and a process to make the same |
| 02/22/2012 | EP2371840A9 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes |
| 02/22/2012 | EP2245028B1 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 02/22/2012 | EP2093228B1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 02/22/2012 | EP2086995B1 Hepatitis c virus inhibitors |
| 02/22/2012 | EP1891071B1 Cyclopropanecarboxylate esters of acyclovir |
| 02/22/2012 | EP1531850B1 Use of IL-21 and monoclonal antibody for treating solid cancers |
| 02/22/2012 | EP1509231B1 System for peritoneal dialysis comprising a reservoir of dialysis solution and a cartridge containing taurolidine powder |
| 02/22/2012 | EP0979080B9 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/22/2012 | CN202146449U 装有洛匹那韦片和利托那韦片剂胶囊 Equipped with lopinavir and ritonavir tablet tablets Capsules |
| 02/22/2012 | CN1939420B 一种新的抗菌抗病毒药物组合物及其制备方法 A new antibacterial antiviral composition and preparation method |
| 02/22/2012 | CN102361875A 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity |
| 02/22/2012 | CN102361644A Anti dengue activity of cissampelos pareira extracts |
| 02/22/2012 | CN102361641A Combination of a nucleoside polymerase inhibitor with a macrocyclic protease inhibitor and use thereof in the treatment of hepatitis C, liver fibrosis and impaired liver function |
| 02/22/2012 | CN102358749A Roxithromycin ambroxol tablet composite and preparing method thereof |
| 02/22/2012 | CN102358744A Cefoxitin sodium crystal compound and cefoxitin sodium composition powder injection |
| 02/22/2012 | CN102358730A Micromolecular methyl ethyl ketone (MEK) protein kinase inhibitor |
| 02/22/2012 | CN102357249A Medicine for inhibiting medicine-resistant tubercle bacillus |
| 02/22/2012 | CN102357245A Purpose of composite of non-crystallin betagamma-crystallin and trefoil factor |
| 02/22/2012 | CN102357221A Chinese patent drug lotion for treating fungal infection of hands |
| 02/22/2012 | CN102357199A Traditional Chinese medicine for treating manus and tinea pedis |
| 02/22/2012 | CN102357185A Traditional Chinese medicine for treating septicemia |
| 02/22/2012 | CN102357176A Anti-cold traditional Chinese medicine composition |
| 02/22/2012 | CN102357168A Chinese medicinal composition for treating gynecological diseases and preparation method thereof |
| 02/22/2012 | CN102357158A Medicament for preventing and curing avian infectious laryngotracheitis and preparation method thereof |
| 02/22/2012 | CN102357155A Traditional Chinese medicine combination for treating herpes zoster |
| 02/22/2012 | CN102357154A Traditional Chinese medicine composition for preventing and treating avian infectious bronchitis and preparation method thereof |
| 02/22/2012 | CN102357153A Traditional Chinese medicine for treating herpes zoster |
| 02/22/2012 | CN102357148A Pure Chinese herbal composition for treating Riemerella anatipestifer disease and preparation method thereof |
| 02/22/2012 | CN102357146A Traditional Chinese medicine for treating beriberi |
| 02/22/2012 | CN102357144A Purslane, safflower, honeysuckle and cortex dictamni mixed powder for treating herpes zoster |
| 02/22/2012 | CN102357127A Chinese herbal medicine for treating influenza |
| 02/22/2012 | CN102357124A Chinese medicine combination with effects of detumescence and inflammatory resistance and preparation method thereof |
| 02/22/2012 | CN102357122A Masking type Chailian oral liquid and preparation method thereof |
| 02/22/2012 | CN102357121A External medicine for treating onychomycosis |
| 02/22/2012 | CN102357116A Healthcare product for mammitis of milch goats |
| 02/22/2012 | CN102357099A Pharmaceutical composition with ornidazole |
| 02/22/2012 | CN102357093A Medicinal composition of methanesulfonic acid arbidol oral solid preparation |
| 02/22/2012 | CN102357092A Use of flavanone natural product 7,3'-dyhydroxy-2',4'-dimethoxy-isoflavane (DDIF) |
| 02/22/2012 | CN102357086A Cefprozil orally disintegrating tablets |
| 02/22/2012 | CN102133297B 治疗急性淋巴结炎的中药制剂 Treatment of Acute lymphadenitis of Chinese medicine |